https://www.selleckchem.com/pr....oducts/tariquidar.ht
le neonatal deaths by 2030, continuous evaluation and improvement of the current guidelines should be a priority on the agenda. The findings of this study encourage the implementation of additional, evidence-based interventions in the current (WHO) guidelines and to be selective in usage of antenatal corticosteroids, to reduce mortality among preterm and LBW neonates in LMICs. Given the global commitment to end all preventable neonatal deaths by 2030, continuous evaluation and improvement of the current guidelines should be a priorit
Like
Comment
Share
